https://scholars.lib.ntu.edu.tw/handle/123456789/536657
標題: | Metformin inhibits TNF-α-induced IκB kinase phosphorylation, IκB-α degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation | 作者: | Huang N.-L. Chiang S.-H. Hsueh C.-H. Liang Y.-J. Chen Y.-J. LING-PING LAI |
關鍵字: | AMP-activated protein kinase; Atherosclerosis; HUVEC; Interleukin-6; Metformin | 公開日期: | 2009 | 卷: | 134 | 期: | 2 | 起(迄)頁: | 169-175 | 來源出版物: | International Journal of Cardiology | 摘要: | Background: Metformin has been reported to reduce cardiovascular complications in diabetic patients. The purpose of the present study was to investigate the anti-inflammatory effects of metformin on endothelial cells and the related molecular mechanisms. Methods: Human umbilical vein endothelial cells (HUVEC) were used for the experiments. The effects of metformin on TNF-α-induced IL-6 production were investigated. Modulation of AMPK and related signal transduction pathways were also performed. Results: TNF-α increased IL-6 secretion by HUVEC in a dose-dependent manner but inhibitors of NF-κB abolished the TNF-α-induced IL-6 production. Pre-treatment with metformin (100-1000?μmol/L) also inhibited TNF-α-induced IL-6 production, phosphorylation of IκB kinase (IKK) α/β and IκB-α degradation. Metformin increased phosphorylation of AMP-activated kinase (AMPK) but wortmannin, a PI3K inhibitor, negated its effects on AMPK phosphorylation and TNF-α-induced IκB-α degradation. AICAR, a direct AMPK activator, had inhibitory effects on TNF-α-induced IL-6 production, similar to that of metformin. Transfection of siRNA against α1-AMPK eradicated the inhibitory effects of metformin on TNF-α-induced IL-6, implying the essential role of AMPK. Conclusions: Metformin had anti-inflammatory effects on endothelial cells and inhibited TNF-α-induced IKKα/β phosphorylation, IκB-α degradation and IL-6 production in HUVEC. This effect was related to PI3K-dependent AMPK phosphorylation. ? 2008 Elsevier Ireland Ltd. All rights reserved. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-64849117472&doi=10.1016%2fj.ijcard.2008.04.010&partnerID=40&md5=63ab2508b4cd1fc87f0a9fff9b4ddafb https://scholars.lib.ntu.edu.tw/handle/123456789/536657 |
ISSN: | 0167-5273 | DOI: | 10.1016/j.ijcard.2008.04.010 | SDG/關鍵字: | 5 amino 4 imidazolecarboxamide riboside; hydroxymethylglutaryl coenzyme A reductase kinase; I kappa B alpha; I kappa B kinase alpha; I kappa B kinase beta; immunoglobulin enhancer binding protein; interleukin 6; metformin; phosphatidylinositol 3 kinase; pyrrolidine dithiocarbamate; small interfering RNA; tumor necrosis factor alpha; wortmannin; antiinflammatory activity; article; controlled study; cytokine production; cytokine release; dose response; endothelium cell; enzyme degradation; enzyme phosphorylation; human; human cell; priority journal; signal transduction; umbilical vein; upregulation; 1-Phosphatidylinositol 3-Kinase; AMP-Activated Protein Kinases; Anti-Inflammatory Agents; Atherosclerosis; Cells, Cultured; Endothelial Cells; Enzyme Activation; Humans; Hypoglycemic Agents; I-kappa B Kinase; Interleukin-6; Metformin; NF-kappa B; Phosphorylation; RNA, Small Interfering; Signal Transduction; Tumor Necrosis Factor-alpha; Umbilical Veins |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。